Cytosorbents Corporation - stock earnings
CTSO Quarterly earnings
Date | Earnings | Revenue |
---|---|---|
2023Q4 | -5.8 million USD | 8.7 million USD |
2023Q3 | -9.2 million USD | 7.8 million USD |
2023Q2 | -6.2 million USD | 8.1 million USD |
2023Q1 | -6.8 million USD | 7.9 million USD |
2022Q4 | -766126 USD | 7.6 million USD |
2022Q3 | -12.2 million USD | 6.5 million USD |
2022Q2 | -10.9 million USD | 7.3 million USD |
2022Q1 | -9.0 million USD | 7.9 million USD |
2021Q4 | -9.3 million USD | 9.7 million USD |
2021Q3 | -6.4 million USD | 8.9 million USD |
2021Q2 | -4.7 million USD | 11.4 million USD |
2021Q1 | -4.2 million USD | 10.1 million USD |
2020Q4 | -677724 USD | 11.5 million USD |
2020Q3 | -840000 USD | 10.2 million USD |
2020Q2 | -2.9 million USD | 9.5 million USD |
2020Q1 | -3.5 million USD | 8.2 million USD |
2019Q4 | -3.9 million USD | 6.6 million USD |
2019Q3 | -6.9 million USD | 5.7 million USD |
2019Q2 | -3.5 million USD | 5.9 million USD |
2019Q1 | -4.9 million USD | 4.6 million USD |
2018Q4 | -5.4 million USD | 5.5 million USD |
2018Q3 | -3.0 million USD | 5.1 million USD |
2018Q2 | -5.8 million USD | 5.2 million USD |
2018Q1 | -3.0 million USD | 4.4 million USD |
2017Q4 | -3.1 million USD | 4.3 million USD |
2017Q3 | -2.1 million USD | 3.4 million USD |
2017Q2 | -1.1 million USD | 3.0 million USD |
2017Q1 | -1.4 million USD | 2.6 million USD |
2016Q4 | -4.4 million USD | 2.6 million USD |
2016Q3 | -2.7 million USD | 2.1 million USD |
2016Q2 | -3.0 million USD | 1.9 million USD |
2016Q1 | -1.8 million USD | 1.6 million USD |
2015Q4 | -2.0 million USD | 1.5 million USD |
2015Q3 | -2.8 million USD | 1.1 million USD |
2015Q2 | 1.4 million USD | 784282 USD |
2015Q1 | -4.7 million USD | 704491 USD |
2014Q4 | -5.0 million USD | 873651 USD |
2014Q3 | -1.5 million USD | 1.0 million USD |
2014Q2 | -1.9 million USD | 665733 USD |
2014Q1 | -975083 USD | 570910 USD |
2013Q4 | -669075 USD | 314159 USD |
2013Q3 | -964789 USD | 203561 USD |
2013Q2 | -1.4 million USD | 127969 USD |
2013Q1 | -537620 USD | -587040 USD |
2012Q4 | -537620 USD | 604322 USD |
2012Q3 | -651980 USD | 605346 USD |
2012Q2 | -1.0 million USD | 33042 USD |
2012Q1 | -1.4 million USD | 16893 USD |
2011Q4 | -1.2 million USD | 36078 USD |
2011Q3 | -1.7 million USD | ? USD |
2011Q2 | -1.3 million USD | ? USD |
2011Q1 | -1.2 million USD | ? USD |
2010Q4 | -475100 USD | ? USD |
2010Q3 | -788436 USD | ? USD |
2010Q2 | -676278 USD | ? USD |
2010Q1 | -283561 USD | ? USD |
2009Q4 | -283561 USD | ? USD |
2009Q3 | -841058 USD | ? USD |
2009Q2 | -851945 USD | ? USD |
2009Q1 | -653412 USD | ? USD |
2008Q4 | -653412 USD | ? USD |
2008Q3 | -862751 USD | ? USD |
2008Q2 | -855637 USD | ? USD |
2008Q1 | -599344 USD | ? USD |
2007Q4 | -599344 USD | ? USD |
2007Q3 | -588827 USD | ? USD |
2007Q2 | -714053 USD | ? USD |
2007Q1 | -1.4 million USD | ? USD |
2006Q4 | -819966 USD | -4145 USD |
2006Q3 | -645703 USD | ? USD |
2006Q2 | -5.2 million USD | ? USD |
2006Q1 | -10845 USD | 4145 USD |
2005Q4 | -8633 USD | 5263 USD |
2005Q3 | -10347 USD | 4183 USD |
2005Q2 | -20000 USD | 4183 USD |
2005Q1 | -10000 USD | ? USD |
2004Q4 | -10000 USD | ? USD |
CTSO Yearly earnings
Date | Earnings | Revenue |
---|---|---|
2023 | -28.5 million USD | 36.3 million USD |
2022 | -32.8 million USD | 29.4 million USD |
2021 | -24.6 million USD | 40.1 million USD |
2020 | -7.8 million USD | 39.5 million USD |
2019 | -19.3 million USD | 22.8 million USD |
2018 | -17.2 million USD | 20.3 million USD |
2017 | -8.5 million USD | 13.4 million USD |
2016 | -11.9 million USD | 8.2 million USD |
2015 | -8.1 million USD | 4.1 million USD |
2014 | -9.3 million USD | 3.1 million USD |
2013 | -4.7 million USD | 821787 USD |
2012 | -3.7 million USD | 151574 USD |
2011 | -5.5 million USD | 36078 USD |
2010 | -2.9 million USD | ? USD |
2009 | -2.7 million USD | ? USD |
2008 | -3.0 million USD | ? USD |
2007 | -3.4 million USD | ? USD |
2006 | -7.7 million USD | ? USD |
2005 | -80000 USD | 10000 USD |
2004 | -80000 USD | 10000 USD |
CTSO
Price: $0.88
52 week price:
Earnings Per Share: -0.64 USD
P/E Ratio: -1.92
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Volume: 305200
Ebitda: -2.1 millionMarket Capitalization: 54.1 million